Myeloma Research NewsUT Southwestern Researcher Tells His CAR-T Therapy Story Ahead of Myeloma TrialMyeloma Research NewsAs UT Southwestern and Celgene Corporation join efforts to launch a new clinical trial to evaluate a chimeric antigen receptor T-ce… Continue reading
Chemical & Engineering NewsGilead and Sangamo deal shows that CRISPR still has competitionChemical & Engineering NewsSangamo says that making and testing its zinc finger nuclease (ZFN) gene-editing technology, once an arduous process, has been greatly … Continue reading
ctDNA Can Flag Pseudoprogression in Melanoma Treated With ImmunotherapyCancer NetworkCirculating tumor DNA (ctDNA) can help differentiate what is known as pseudoprogression from true progression of disease in patients with melanoma who are treated with… Continue reading
Reuropebluebird bio Updates Plans for the Year AheadFox BusinessAt the American Society of Hematology (ASH) Annual Meeting in December, Bluebird presented promising data for its updated manufacturing process for LentiGlobin, its gene therapy for transf… Continue reading
Evolution of Engineered Organisms Constrains BioproductionGenetic Engineering & Biotechnology News"Based on these findings I would encourage companies running industrial-scale fermentations to deploy deep sequencing of the fermentation populations… Continue reading
EurekAlert (press release)Stem cell study may result in stronger muscles in old ageEurekAlert (press release)A new study by researchers at Karolinska Institutet in Sweden shows how an unexpectedly high number of mutations in the stem cells of muscles i… Continue reading
EurekAlert (press release)Stem cell study may result in stronger muscles in old age – EurekAlert!EurekAlert (press release)As we grow older, our muscular function declines. A new study by researchers at Karolinska Institutet in Sweden shows how an unex… Continue reading
Fate Therapeutics Wins $4M Grant to Advance NK Cancer ImmunotherapyGenetic Engineering & Biotechnology NewsFate Therapeutics said today it has won a $4 million California Institute for Regenerative Medicine (CIRM) grant toward advancing one of its off-… Continue reading